To The Moon

$Kala Pharmaceuticals Inc.(KALA)$ Great news and I believe this stock should hit $100 soon, will sell some to profit before then. On Friday, 30th Dec 2022, Kala Pharmaceuticals Inc stock price rose 53.58%, starting from $24.84 and ending at $38.15. This marked the sixth consecutive day of gains, which is an uncommon occurrence. The stock fluctuated 54.23% throughout the day, ranging from $29.17 to $44.99. Over the past two weeks, the price has increased by 771%. The trading volume decreased by -10 million shares, totaling 19 million shares traded for a total of $712.43 million. A decrease in volume on higher prices may indicate a potential change in the near future. Here's how to buy KALA stock if you're new to investing. The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $15.09, a level that may pose a second chance to hit a runner. KALA Signals & Forecast The Kala Pharmaceuticals Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.96 and $6.91. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, December 22, 2022, and so far it has risen 939.51%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Support, Risk & Stop-loss for Kala Pharmaceuticals Inc stock There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days. $38.15 This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $15.82 between high and low, or 54.23%. For the last week, the stock has had daily average volatility of 78.11%. The Kala Pharmaceuticals Inc stock is extremely overbought on RSI14 (96). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the Kala Pharmaceuticals Inc has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution. Our recommended stop-loss: $37.17 (-2.58%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 96 and this increases the risk substantially. There is a buy signal from a pivot bottom found 5 days ago.) Trading Expectations (KALA) For The Upcoming Trading Day Of Tuesday 3rd For the upcoming trading day on Tuesday, 3rd we expect Kala Pharmaceuticals Inc to open at $37.44, and during the day (based on 14 day Average True Range), to move between $34.39 and $41.91, which gives a possible trading interval of +/-$3.76 (+/-9.85%) up or down from last closing price. If Kala Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 19.70% move between the lowest and the highest trading price during the day. Insiders are neutral as most recent trades are sells in Kala Pharmaceuticals Inc In the last 100 trades there were 9.78 million shares bought and 5.65 million shares sold. The last trade was made 63 days ago by Farid Marjan who bough 1.6 thousand shares. For the period there has been more stocks bought than sold among the insiders, but most of the latest transaction have been insiders selling. There can be a variety of reasons for this, but the stock should be watched more closely. Is Kala Pharmaceuticals Inc stock A Buy? Kala Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.